参考文献:1. Qi WX, Tang LN, He AN, Shen Z, Lin F, Yao Y (2012) Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis. Lung Jun 19. [Epub ahead of print] 2. Vasques F, Messori A, Lucenteforte E, Biancari F (2012) Immediate and late outcome of patients aged 80聽years and older undergoing isolated aortic valve replacement: a systematic review and meta-analysis of 48 studies. Am Heart J 163(3):477鈥?85 CrossRef 3. Messori A, Fadda V, Maratea D, Trippoli S (2012) Meta-analysis of observational studies to evaluate immediate outcomes after endarterectomy or stenting for carotid artery stenosis. Ann Vasc Surg 26(8):1166鈥?167 CrossRef 4. Messori A, Del Santo F, Fadda V, Maratea D, Trippol S (2012) Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis. Eur J Clin Pharmacol 68(4):441鈥?42 CrossRef 5. Biondi-Zoccai GG, Abbate A, Agostoni P et al (2005) Long-term benefits of an early invasive management in acute coronary syndromes significantly depend on intracoronary stenting and aggressive antiplatelet treatment: a meta-regression. Am Heart J 149:504鈥?11 CrossRef 6. Thompson SG, Higgins JPT (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559鈥?573 CrossRef 7. Cuppone F, Bria E, Vaccaro V, Puglisi F, Fabi A, Sperduti I, Carlini P, Milella M, Nistico C, Russillo M, Papaldo P, Ferretti G, Aapro M, Giannarelli D, Cognetti F (2011) Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: meta-regression analysis of randomized trials. J Exp Clin Cancer Res 30:54 CrossRef 8. Fulan H, Changxing J, Baina WY, Wencui Z, Chunqing L, Fan W, Dandan L, Dianjun S, Tong W, Da P, Yashuang Z (2011) Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes Control 22:1383鈥?396 CrossRef 9. Des Guetz G, Uzzan B, Nicolas P, Valeyre D, Sebbane G, Morere J-F (2012) Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2012.03.007 10. Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavole A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducolone A, Lebitasy MP, Baudrin L, Laporte S, Milleron B (2011) Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 378:1079鈥?088 CrossRef
1. HTA Unit, ESTAV Toscana Centro, Regional Health Service, 50100, Florence, Italy 2. HTA Unit, Area Vasta Centro Toscana, Regional Health System, Via Guimaraes 9-11, 59100, Prato, Italy